Menu
609 Health was built on the front lines of access disruption.
We helped lead the commercial strategy for Mounjaro and Zepbound, tackling access and affordability challenges head-on in one of the most competitive therapeutic spaces in history. From NBRx-to-fill drop-off to prior authorization gridlock, we don’t just observe where patients fall off—we design and implement solutions that pull them through.
When Eli Lilly launched LillyDirect, its first-ever direct-to-consumer pharmacy experience, 609 Health was in the room.
We were instrumental in connecting Lilly with Surescripts to enable pharmacy transaction visibility and integrate benefit insights into the digital experience. This wasn’t just a vendor connection—it was a foundational move that set the stage for a new model of manufacturer-owned pharmacy channels.
As pharma increasingly looks to go DTC for affordability, fulfillment, and control, 609 Health stands apart with deep connectivity across manufacturers, EHR vendors, retail pharmacy partners, and digital infrastructure players.
Access is no longer a back-office function—it’s now a driver of brand growth, patient loyalty, and market share.
609 Health uses data and workflow expertise to surface where friction exists—cost exposure, step therapy misalignment, pharmacy barriers—and build interventions that solve it.
Capabilities include:
Embedding in-EHR access tools (PA status, benefit verification, affordability messaging)
Identifying drop-off points with PLD + claims data and correcting them in-market
Advising on gross-to-net strategy for DTC fulfillment models
Measuring the ROI of affordability programs and patient support across channels
We don’t sell templates—we bring lived experience.
609 Health combines strategic leadership from the Mounjaro and Zepbound launches with rare executional insight into how market access, affordability, and EHR integration actually work in the real world. We’ve worked inside the brand, across the system, and alongside innovators rewriting the playbook.
Why leading brands work with 609 Health:
We pioneered the integration of LillyDirect and Surescripts for pharmacy visibility
We know how to operationalize affordability inside the EHR—not just design it
We work at the speed of market shifts, not quarterly refreshes
We translate access strategy into clinical tools, patient experience, and HCP action
A system that stalis while people suffer isn’t healthcare. It’s time to innovate like lives depend on it-because they do.
A system that stalls while people suffer isn’t healthcare. It’s time to innovate like lives depend on it, because they do.